We are live on ! Find out more
GBT

Global Blood Therapeutics, Inc.
GBT

Delisted

GBT was delisted on the 4th of October, 2022.

Back to rankings

116 hedge funds and large institutions have $1.16B invested in Global Blood Therapeutics, Inc. in 2017 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 41 increasing their positions, 25 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

215% more capital invested

Capital invested by funds: $367M → $1.16B (+$788M)

137% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 19

100% more funds holding in top 10

Funds holding in top 10: 3 → 6 (+3)

64% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 25

42% more call options, than puts

Call options by funds: $19M | Put options by funds: $13.4M

21% more funds holding

Funds holding: 96 → 116 (+20)

Holders
116
Holders Change
+20
Holders Change %
+20.83%
% of All Funds
2.89%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.15%
New
45
Increased
41
Reduced
25
Closed
19
Calls
$19M
Puts
$13.4M
Net Calls
+$5.58M
Net Calls Change
+$5.6M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$64.6M
2
WSC
White Square Capital
United Kingdom
+$36.6M
3
O
OrbiMed
New York
+$27.3M
4
Citadel Advisors
Citadel Advisors
Florida
+$20.3M
5
PA
Perceptive Advisors
New York
+$18.4M

Top Sellers

Rank Fund Capital Flow
1
SAM
Sectoral Asset Management
Quebec, Canada
-$19.7M
2
GPP
Great Point Partners
Connecticut
-$17.6M
3
Marshall Wace
Marshall Wace
United Kingdom
-$10.5M
4
JHIU
Janus Henderson Investors US
Colorado
-$6.73M
5
Prudential Financial
Prudential Financial
New Jersey
-$5.61M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCM
26
Tekla Capital Management
Massachusetts
$6.36M -$5.26M -208,800 -55%
EAM
27
Eventide Asset Management
Massachusetts
$6.08M – – –
TA
28
Teachers Advisors
New York
$5.76M +$3.19M +126,513 +426%
RSCM
29
Rock Springs Capital Management
Maryland
$5.53M +$1.35M +53,500 +55%
DCM
30
Driehaus Capital Management
Illinois
$5.37M +$3.67M +145,582 New
Bank of New York Mellon
31
Bank of New York Mellon
New York
$5.14M +$1.55M +61,593 +79%
TCIM
32
TIAA CREF Investment Management
New York
$4.81M +$949K +37,672 +41%
Wells Fargo
33
Wells Fargo
California
$4.44M +$614K +24,363 +25%
CCM
34
Century Capital Management
Massachusetts
$4.42M -$1.5M -59,654 -33%
OAM
35
Oxford Asset Management
United Kingdom
$4.37M -$563K -22,350 -16%
YCMGA
36
York Capital Management Global Advisors
New York
$4.24M +$2.9M +115,000 New
Charles Schwab
37
Charles Schwab
California
$4.08M +$1.12M +44,383 +67%
Goldman Sachs
38
Goldman Sachs
New York
$3.75M +$1.57M +62,231 +157%
CC
39
Casdin Capital
New York
$3.74M -$5.1M -202,500 -67%
Barclays
40
Barclays
United Kingdom
$3.59M +$1.76M +70,057 +256%
EI
41
EAM Investors
California
$3.55M +$2.42M +96,225 New
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
$3.51M +$2.4M +95,230 New
CS
43
Credit Suisse
Switzerland
$3.36M -$62K -2,461 -3%
Voloridge Investment Management
44
Voloridge Investment Management
Florida
$3.34M +$2.28M +90,655 New
CS
45
Candriam SCA
Luxembourg
$2.84M – – –
Deutsche Bank
46
Deutsche Bank
Germany
$2.79M +$991K +39,361 +108%
Prudential Financial
47
Prudential Financial
New Jersey
$2.77M -$5.61M -222,930 -75%
MIM
48
Monashee Investment Management
Massachusetts
$2.76M – – –
CLOS
49
Compagnie Lombard Odier SCmA
Switzerland
$2.37M +$1.62M +64,379 New
PVI
50
Pura Vida Investments
New York
$2.23M +$1.53M +60,598 New
1
2
3 4 5

GBT Hedge Fund Activity: Q1 2017 in Review

116 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Global Blood Therapeutics, Inc. (GBT) for Q1 2017, worth a combined $1.16B — up 215% from $367M a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new GBT positions and 19 closed out — a net gain of 26 holders — while 41 added to existing stakes and 25 trimmed.

The largest buyer was BlackRock, adding an estimated $64.6M. The largest seller was Sectoral Asset Management, cutting an estimated $19.7M.

  • 116 institutional investors held Global Blood Therapeutics, Inc. (GBT) as of Q1 2017, up from 96 in Q4 2016.
  • Funds reported $1.16B of Global Blood Therapeutics, Inc. stock for Q1 2017, up 215% quarter-over-quarter.
  • 45 funds opened new Global Blood Therapeutics, Inc. positions in Q1 2017 and 19 closed out, a net change of +26 holders.
  • The largest Global Blood Therapeutics, Inc. buyer in Q1 2017 was BlackRock, an estimated $64.6M added.
  • The largest Global Blood Therapeutics, Inc. seller in Q1 2017 was Sectoral Asset Management, an estimated $19.7M sold.

Based on aggregated 13F filings for Q1 2017.